Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc244_6, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 6 input genes in category / 51 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0034593 phosphatidylinositol bisphosphate phosphatase activity 2.434E-7 7.596E-6 3.433E-5 1.241E-5 3 44
2 GO:0052866 phosphatidylinositol phosphate phosphatase activity 2.979E-7 7.596E-6 3.433E-5 1.519E-5 3 47
3 GO:0004438 phosphatidylinositol-3-phosphatase activity 7.827E-6 1.331E-4 6.012E-4 3.992E-4 2 14
4 GO:0043813 phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity 2.790E-5 3.253E-4 1.470E-3 1.423E-3 2 26
5 GO:0052629 phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity 3.990E-5 3.253E-4 1.470E-3 2.035E-3 2 31
6 GO:0052744 phosphatidylinositol monophosphate phosphatase activity 4.255E-5 3.253E-4 1.470E-3 2.170E-3 2 32
7 GO:0005158 insulin receptor binding 4.811E-5 3.253E-4 1.470E-3 2.454E-3 2 34
8 GO:0034595 phosphatidylinositol phosphate 5-phosphatase activity 5.102E-5 3.253E-4 1.470E-3 2.602E-3 2 35
9 GO:0016791 phosphatase activity 6.603E-5 3.742E-4 1.691E-3 3.367E-3 3 282
10 GO:0008138 protein tyrosine/serine/threonine phosphatase activity 1.831E-4 9.339E-4 4.220E-3 9.339E-3 2 66
11 GO:0042578 phosphoric ester hydrolase activity 2.292E-4 1.062E-3 4.801E-3 1.169E-2 3 429
12 GO:0000285 1-phosphatidylinositol-3-phosphate 5-kinase activity 9.643E-4 4.098E-3 1.852E-2 4.918E-2 1 3
13 GO:0004721 phosphoprotein phosphatase activity 1.537E-3 6.031E-3 2.725E-2
7.840E-2
2 192
14 GO:0016308 1-phosphatidylinositol-4-phosphate 5-kinase activity 2.570E-3 9.361E-3 4.230E-2
1.311E-1
1 8
15 GO:0005068 transmembrane receptor protein tyrosine kinase adaptor activity 3.853E-3 1.277E-2
5.770E-2
1.965E-1
1 12
16 GO:0043726 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity 7.373E-3 1.277E-2
5.770E-2
3.760E-1
1 23
17 GO:1990003 IDP phosphatase activity 7.373E-3 1.277E-2
5.770E-2
3.760E-1
1 23
18 GO:0052867 phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity 7.373E-3 1.277E-2
5.770E-2
3.760E-1
1 23
19 GO:0019178 NADP phosphatase activity 7.373E-3 1.277E-2
5.770E-2
3.760E-1
1 23
20 GO:0016307 phosphatidylinositol phosphate kinase activity 7.373E-3 1.277E-2
5.770E-2
3.760E-1
1 23
21 GO:0052829 inositol-1,3,4-trisphosphate 1-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
22 GO:0052831 inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
23 GO:0052830 inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
24 GO:0030351 inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
25 GO:0043812 phosphatidylinositol-4-phosphate phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
26 GO:0052825 inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
27 GO:0030352 inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
28 GO:0008579 JUN kinase phosphatase activity 7.693E-3 1.277E-2
5.770E-2
3.923E-1
1 24
29 GO:0052827 inositol pentakisphosphate phosphatase activity 8.012E-3 1.277E-2
5.770E-2
4.086E-1
1 25
30 GO:0052828 inositol-3,4-bisphosphate 4-phosphatase activity 8.012E-3 1.277E-2
5.770E-2
4.086E-1
1 25
31 GO:0030487 inositol-4,5-bisphosphate 5-phosphatase activity 8.012E-3 1.277E-2
5.770E-2
4.086E-1
1 25
32 GO:0017161 inositol-1,3,4-trisphosphate 4-phosphatase activity 8.012E-3 1.277E-2
5.770E-2
4.086E-1
1 25
33 GO:0098519 nucleotide phosphatase activity, acting on free nucleotides 8.332E-3 1.288E-2
5.819E-2
4.249E-1
1 26
34 GO:0008330 protein tyrosine/threonine phosphatase activity 8.651E-3 1.298E-2
5.864E-2
4.412E-1
1 27
35 GO:0034594 phosphatidylinositol trisphosphate phosphatase activity 9.608E-3 1.324E-2
5.985E-2
4.900E-1
1 30
36 GO:0034596 phosphatidylinositol phosphate 4-phosphatase activity 9.608E-3 1.324E-2
5.985E-2
4.900E-1
1 30
37 GO:0016312 inositol bisphosphate phosphatase activity 9.608E-3 1.324E-2
5.985E-2
4.900E-1
1 30
38 GO:0052743 inositol tetrakisphosphate phosphatase activity 1.088E-2 1.461E-2
6.601E-2
5.551E-1
1 34
39 GO:0017017 MAP kinase tyrosine/serine/threonine phosphatase activity 1.152E-2 1.473E-2
6.655E-2
5.876E-1
1 36
40 GO:0046030 inositol trisphosphate phosphatase activity 1.184E-2 1.473E-2
6.655E-2
6.038E-1
1 37
41 GO:0033549 MAP kinase phosphatase activity 1.184E-2 1.473E-2
6.655E-2
6.038E-1
1 37
42 GO:0019198 transmembrane receptor protein phosphatase activity 1.279E-2 1.554E-2
7.020E-2
6.525E-1
1 40
43 GO:0052745 inositol phosphate phosphatase activity 1.438E-2 1.706E-2
7.709E-2
7.336E-1
1 45
44 GO:0030971 receptor tyrosine kinase binding 1.914E-2 2.218E-2
1.002E-1
9.761E-1
1 60
45 GO:1990782 protein tyrosine kinase binding 2.104E-2 2.384E-2
1.077E-1
1.000E0
1 66
46 GO:0035591 signaling adaptor activity 2.482E-2 2.752E-2
1.244E-1
1.000E0
1 78
47 GO:0019209 kinase activator activity 2.734E-2 2.966E-2
1.341E-1
1.000E0
1 86
48 GO:0004725 protein tyrosine phosphatase activity 3.267E-2 3.471E-2
1.568E-1
1.000E0
1 103
Show 43 more annotations

2: GO: Biological Process [Display Chart] 6 input genes in category / 108 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0032288 myelin assembly 2.114E-8 1.653E-6 8.702E-6 2.283E-6 3 20
2 GO:0006661 phosphatidylinositol biosynthetic process 3.062E-8 1.653E-6 8.702E-6 3.306E-6 4 127
3 GO:0046488 phosphatidylinositol metabolic process 1.982E-7 6.253E-6 3.291E-5 2.140E-5 4 202
4 GO:0046474 glycerophospholipid biosynthetic process 2.316E-7 6.253E-6 3.291E-5 2.501E-5 4 210
5 GO:0045017 glycerolipid biosynthetic process 4.021E-7 8.654E-6 4.555E-5 4.343E-5 4 241
6 GO:0008654 phospholipid biosynthetic process 4.808E-7 8.654E-6 4.555E-5 5.192E-5 4 252
7 GO:0006650 glycerophospholipid metabolic process 1.158E-6 1.787E-5 9.406E-5 1.251E-4 4 314
8 GO:0031642 negative regulation of myelination 2.420E-6 3.267E-5 1.720E-4 2.614E-4 2 8
9 GO:0046486 glycerolipid metabolic process 3.257E-6 3.908E-5 2.057E-4 3.518E-4 4 407
10 GO:0006644 phospholipid metabolic process 3.869E-6 4.178E-5 2.200E-4 4.178E-4 4 425
11 GO:0042552 myelination 5.275E-6 4.604E-5 2.424E-4 5.697E-4 3 121
12 GO:0007272 ensheathment of neurons 5.542E-6 4.604E-5 2.424E-4 5.986E-4 3 123
13 GO:0008366 axon ensheathment 5.542E-6 4.604E-5 2.424E-4 5.986E-4 3 123
14 GO:0031645 negative regulation of neurological system process 1.476E-5 1.138E-4 5.992E-4 1.594E-3 2 19
15 GO:0031641 regulation of myelination 5.732E-5 4.127E-4 2.173E-3 6.191E-3 2 37
16 GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process 1.010E-4 6.821E-4 3.590E-3 1.091E-2 2 49
17 GO:0010927 cellular component assembly involved in morphogenesis 1.118E-4 7.104E-4 3.739E-3 1.208E-2 3 336
18 GO:0031644 regulation of neurological system process 3.124E-4 1.874E-3 9.867E-3 3.374E-2 2 86
19 GO:1904562 phosphatidylinositol 5-phosphate metabolic process 6.443E-4 3.662E-3 1.928E-2
6.958E-2
1 2
20 GO:2000645 negative regulation of receptor catabolic process 9.663E-4 5.218E-3 2.747E-2
1.044E-1
1 3
21 GO:0007033 vacuole organization 1.948E-3 1.002E-2
5.273E-2
2.104E-1
2 216
22 GO:2000644 regulation of receptor catabolic process 2.575E-3 1.157E-2
6.091E-2
2.781E-1
1 8
23 GO:2000643 positive regulation of early endosome to late endosome transport 2.575E-3 1.157E-2
6.091E-2
2.781E-1
1 8
24 GO:0002091 negative regulation of receptor internalization 2.575E-3 1.157E-2
6.091E-2
2.781E-1
1 8
25 GO:0030258 lipid modification 2.702E-3 1.157E-2
6.091E-2
2.918E-1
2 255
26 GO:0016197 endosomal transport 2.786E-3 1.157E-2
6.091E-2
3.008E-1
2 259
27 GO:0097062 dendritic spine maintenance 2.897E-3 1.159E-2
6.099E-2
3.128E-1
1 9
28 GO:0090394 negative regulation of excitatory postsynaptic potential 3.218E-3 1.241E-2
6.534E-2
3.475E-1
1 10
29 GO:0007034 vacuolar transport 3.431E-3 1.278E-2
6.726E-2
3.706E-1
2 288
30 GO:0046855 inositol phosphate dephosphorylation 3.860E-3 1.346E-2
7.087E-2
4.169E-1
1 12
31 GO:0051961 negative regulation of nervous system development 3.939E-3 1.346E-2
7.087E-2
4.254E-1
2 309
32 GO:0006898 receptor-mediated endocytosis 3.989E-3 1.346E-2
7.087E-2
4.308E-1
2 311
33 GO:0046838 phosphorylated carbohydrate dephosphorylation 4.182E-3 1.368E-2
7.201E-2
4.516E-1
1 13
34 GO:0071545 inositol phosphate catabolic process 4.503E-3 1.368E-2
7.201E-2
4.863E-1
1 14
35 GO:1903337 positive regulation of vacuolar transport 4.503E-3 1.368E-2
7.201E-2
4.863E-1
1 14
36 GO:0007265 Ras protein signal transduction 4.560E-3 1.368E-2
7.201E-2
4.924E-1
2 333
37 GO:2000641 regulation of early endosome to late endosome transport 5.145E-3 1.502E-2
7.905E-2
5.556E-1
1 16
38 GO:0048261 negative regulation of receptor-mediated endocytosis 5.465E-3 1.553E-2
8.177E-2
5.903E-1
1 17
39 GO:0046174 polyol catabolic process 6.748E-3 1.869E-2
9.836E-2
7.288E-1
1 21
40 GO:0032801 receptor catabolic process 7.709E-3 2.065E-2
1.087E-1
8.325E-1
1 24
41 GO:0016311 dephosphorylation 8.018E-3 2.065E-2
1.087E-1
8.659E-1
2 445
42 GO:0046856 phosphatidylinositol dephosphorylation 8.029E-3 2.065E-2
1.087E-1
8.671E-1
1 25
43 GO:0043954 cellular component maintenance 9.308E-3 2.285E-2
1.203E-1
1.000E0
1 29
44 GO:1903335 regulation of vacuolar transport 9.308E-3 2.285E-2
1.203E-1
1.000E0
1 29
45 GO:0045022 early endosome to late endosome transport 1.123E-2 2.494E-2
1.313E-1
1.000E0
1 35
46 GO:2000785 regulation of autophagosome assembly 1.123E-2 2.494E-2
1.313E-1
1.000E0
1 35
47 GO:0045742 positive regulation of epidermal growth factor receptor signaling pathway 1.123E-2 2.494E-2
1.313E-1
1.000E0
1 35
48 GO:0098815 modulation of excitatory postsynaptic potential 1.154E-2 2.494E-2
1.313E-1
1.000E0
1 36
49 GO:1901186 positive regulation of ERBB signaling pathway 1.154E-2 2.494E-2
1.313E-1
1.000E0
1 36
50 GO:0046839 phospholipid dephosphorylation 1.154E-2 2.494E-2
1.313E-1
1.000E0
1 36
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 6 input genes in category / 28 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0031901 early endosome membrane 1.804E-8 5.050E-7 1.983E-6 5.050E-7 4 114
2 GO:0005769 early endosome 1.056E-6 1.478E-5 5.806E-5 2.957E-5 4 314
3 GO:0010008 endosome membrane 2.745E-6 2.148E-5 8.434E-5 7.685E-5 4 399
4 GO:0031902 late endosome membrane 3.494E-6 2.148E-5 8.434E-5 9.785E-5 3 108
5 GO:0044440 endosomal part 3.835E-6 2.148E-5 8.434E-5 1.074E-4 4 434
6 GO:0005770 late endosome 3.120E-5 1.456E-4 5.718E-4 8.737E-4 3 224
7 GO:0070772 PAS complex 3.148E-4 1.259E-3 4.945E-3 8.814E-3 1 1
8 GO:0035032 phosphatidylinositol 3-kinase complex, class III 2.202E-3 7.706E-3 3.026E-2
6.165E-2
1 7
9 GO:0032593 insulin-responsive compartment 2.830E-3 8.805E-3 3.458E-2
7.924E-2
1 9
10 GO:0005942 phosphatidylinositol 3-kinase complex 6.280E-3 1.758E-2
6.905E-2
1.758E-1
1 20
Show 5 more annotations

4: Human Phenotype [Display Chart] 4 input genes in category / 349 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 6 input genes in category / 331 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0010829 increased bronchioalveolar stem cell number 2.796E-6 6.939E-4 4.428E-3 9.255E-4 2 5
2 MP:0010828 abnormal bronchioalveolar stem cell morphology 4.193E-6 6.939E-4 4.428E-3 1.388E-3 2 6
3 MP:0000371 diluted coat color 7.480E-6 8.253E-4 5.266E-3 2.476E-3 3 76
4 MP:0004202 pulmonary hyperplasia 1.257E-5 9.709E-4 6.195E-3 4.159E-3 2 10
5 MP:0010901 abnormal pulmonary alveolar parenchyma morphology 1.467E-5 9.709E-4 6.195E-3 4.855E-3 3 95
6 MP:0002654 spongiform encephalopathy 3.791E-5 2.091E-3 1.334E-2 1.255E-2 2 17
7 MP:0005481 increased chronic myelocytic leukemia incidence 5.292E-5 2.419E-3 1.544E-2 1.752E-2 2 20
8 MP:0010810 increased type II pneumocyte number 5.847E-5 2.419E-3 1.544E-2 1.935E-2 2 21
9 MP:0011178 increased erythroblast number 1.208E-4 4.275E-3 2.728E-2 4.000E-2 2 30
10 MP:0009321 increased histiocytic sarcoma incidence 1.291E-4 4.275E-3 2.728E-2 4.275E-2 2 31
11 MP:0011177 abnormal erythroblast number 2.161E-4 6.503E-3 4.150E-2
7.154E-2
2 40
12 MP:0011176 abnormal erythroblast morphology 2.990E-4 6.946E-3 4.432E-2
9.896E-2
2 47
13 MP:0003105 abnormal heart atrium morphology 3.165E-4 6.946E-3 4.432E-2
1.048E-1
3 266
14 MP:0008254 increased megakaryocyte cell number 3.251E-4 6.946E-3 4.432E-2
1.076E-1
2 49
15 MP:0010899 abnormal pulmonary alveolar system morphology 3.381E-4 6.946E-3 4.432E-2
1.119E-1
3 272
16 MP:0000321 increased bone marrow cell number 3.523E-4 6.946E-3 4.432E-2
1.166E-1
2 51
17 MP:0002075 abnormal coat/hair pigmentation 3.567E-4 6.946E-3 4.432E-2
1.181E-1
3 277
18 MP:0002651 abnormal sciatic nerve morphology 3.805E-4 6.998E-3 4.465E-2
1.260E-1
2 53
19 MP:0020202 abnormal macrophage cell number 4.042E-4 7.042E-3 4.494E-2
1.338E-1
3 289
20 MP:0000848 abnormal pons morphology 4.559E-4 7.545E-3 4.814E-2
1.509E-1
2 58
21 MP:0004882 enlarged lung 5.551E-4 7.672E-3 4.895E-2
1.838E-1
2 64
22 MP:0002275 abnormal type II pneumocyte morphology 5.551E-4 7.672E-3 4.895E-2
1.838E-1
2 64
23 MP:0005075 abnormal melanosome morphology 5.726E-4 7.672E-3 4.895E-2
1.895E-1
2 65
24 MP:0000745 tremors 5.762E-4 7.672E-3 4.895E-2
1.907E-1
3 326
25 MP:0030914 abnormal endosome to melanosome transport 5.794E-4 7.672E-3 4.895E-2
1.918E-1
1 1
26 MP:0000322 increased granulocyte number 7.459E-4 9.341E-3
5.961E-2
2.469E-1
3 356
27 MP:0005403 abnormal nerve conduction 7.620E-4 9.341E-3
5.961E-2
2.522E-1
2 75
28 MP:0002273 abnormal pulmonary alveolus epithelial cell morphology 8.030E-4 9.404E-3
6.001E-2
2.658E-1
2 77
29 MP:0002027 increased lung adenocarcinoma incidence 8.240E-4 9.404E-3
6.001E-2
2.727E-1
2 78
30 MP:0010898 abnormal pulmonary alveolus epithelium morphology 8.883E-4 9.801E-3
6.254E-2
2.940E-1
2 81
31 MP:0002416 abnormal proerythroblast morphology 9.325E-4 9.957E-3
6.353E-2
3.087E-1
2 83
32 MP:0008716 increased lung non-small cell carcinoma incidence 9.778E-4 1.011E-2
6.453E-2
3.236E-1
2 85
33 MP:0000709 enlarged thymus 1.071E-3 1.065E-2
6.797E-2
3.546E-1
2 89
34 MP:0002026 increased leukemia incidence 1.144E-3 1.065E-2
6.797E-2
3.788E-1
2 92
35 MP:0030915 abnormal melanosome maturation 1.159E-3 1.065E-2
6.797E-2
3.835E-1
1 2
36 MP:0014229 decreased alveolar macrophage number 1.159E-3 1.065E-2
6.797E-2
3.835E-1
1 2
37 MP:0008535 enlarged lateral ventricles 1.324E-3 1.159E-2
7.393E-2
4.382E-1
2 99
38 MP:0002364 abnormal thymus size 1.330E-3 1.159E-2
7.393E-2
4.403E-1
3 434
39 MP:0002877 abnormal melanocyte morphology 1.488E-3 1.263E-2
8.057E-2
4.924E-1
2 105
40 MP:0008714 increased lung carcinoma incidence 1.544E-3 1.278E-2
8.154E-2
5.112E-1
2 107
41 MP:0002417 abnormal megakaryocyte morphology 1.631E-3 1.317E-2
8.404E-2
5.400E-1
2 110
42 MP:0014227 abnormal alveolar macrophage number 1.737E-3 1.364E-2
8.702E-2
5.751E-1
1 3
43 MP:0002446 abnormal macrophage morphology 1.772E-3 1.364E-2
8.702E-2
5.864E-1
3 479
44 MP:0001186 pigmentation phenotype 1.859E-3 1.398E-2
8.922E-2
6.152E-1
3 487
45 MP:0013660 abnormal bone marrow hematopoietic cell morphology 1.906E-3 1.402E-2
8.946E-2
6.309E-1
2 119
46 MP:0001077 abnormal spinal nerve morphology 2.101E-3 1.512E-2
9.645E-2
6.953E-1
2 125
47 MP:0003354 astrocytosis 2.270E-3 1.533E-2
9.783E-2
7.513E-1
2 130
48 MP:0011748 intestinal fibrosis 2.316E-3 1.533E-2
9.783E-2
7.666E-1
1 4
49 MP:0014226 abnormal alveolar macrophage physiology 2.316E-3 1.533E-2
9.783E-2
7.666E-1
1 4
50 MP:0012503 increased midbrain apoptosis 2.316E-3 1.533E-2
9.783E-2
7.666E-1
1 4
Show 45 more annotations

6: Domain [Display Chart] 6 input genes in category / 67 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 SM00310 PTBI SMART 4.695E-6 1.301E-4 6.229E-4 3.146E-4 2 11
2 PS51064 IRS PTB PROSITE 5.633E-6 1.301E-4 6.229E-4 3.774E-4 2 12
3 PF02174 IRS Pfam 7.765E-6 1.301E-4 6.229E-4 5.202E-4 2 14
4 IPR002404 IRS PTB InterPro 7.765E-6 1.301E-4 6.229E-4 5.202E-4 2 14
5 2.30.29.30 - Gene3D 1.722E-4 2.307E-3 1.105E-2 1.154E-2 3 391
6 IPR011993 PH dom-like InterPro 2.234E-4 2.384E-3 1.142E-2 1.497E-2 3 427
7 IPR026825 Vac14 InterPro 3.203E-4 2.384E-3 1.142E-2 2.146E-2 1 1
8 IPR021841 VAC14 Fig4p-bd InterPro 3.203E-4 2.384E-3 1.142E-2 2.146E-2 1 1
9 PF11916 Vac14 Fig4 bd Pfam 3.203E-4 2.384E-3 1.142E-2 2.146E-2 1 1
10 IPR032878 Vac14 Fab1-bd InterPro 6.404E-4 3.901E-3 1.868E-2 4.291E-2 1 2
11 PF12755 Vac14 Fab1 bd Pfam 6.404E-4 3.901E-3 1.868E-2 4.291E-2 1 2
12 PF02383 Syja N Pfam 1.600E-3 7.456E-3 3.571E-2
1.072E-1
1 5
13 PS50275 SAC PROSITE 1.600E-3 7.456E-3 3.571E-2
1.072E-1
1 5
14 IPR002013 SAC dom InterPro 1.600E-3 7.456E-3 3.571E-2
1.072E-1
1 5
15 PF00169 PH Pfam 2.179E-3 7.456E-3 3.571E-2
1.460E-1
2 230
16 SM00330 PIPKc SMART 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
17 PS51455 PIPK PROSITE 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
18 IPR002498 PInositol-4-P-5-kinase core InterPro 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
19 3.30.800.10 - Gene3D 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
20 PF01504 PIP5K Pfam 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
21 IPR027484 PInositol-4-P-5-kinase N InterPro 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
22 IPR027483 PInositol-4-P-5-kinase C InterPro 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
23 3.30.810.10 - Gene3D 2.560E-3 7.456E-3 3.571E-2
1.715E-1
1 8
24 SM00233 PH SMART 3.186E-3 8.327E-3 3.988E-2
2.135E-1
2 279
25 PS50003 PH DOMAIN PROSITE 3.209E-3 8.327E-3 3.988E-2
2.150E-1
2 280
26 IPR001849 PH domain InterPro 3.231E-3 8.327E-3 3.988E-2
2.165E-1
2 281
27 3.30.260.10 - Gene3D 3.518E-3 8.418E-3 4.032E-2
2.357E-1
1 11
28 IPR027410 TCP-1-like intermed InterPro 3.518E-3 8.418E-3 4.032E-2
2.357E-1
1 11
29 IPR030564 Myotubularin fam InterPro 4.476E-3 8.924E-3 4.274E-2
2.999E-1
1 14
30 PF06602 Myotub-related Pfam 4.476E-3 8.924E-3 4.274E-2
2.999E-1
1 14
31 IPR010569 Myotubularin-like Pase dom InterPro 4.476E-3 8.924E-3 4.274E-2
2.999E-1
1 14
32 PS51339 PPASE MYOTUBULARIN PROSITE 4.476E-3 8.924E-3 4.274E-2
2.999E-1
1 14
33 PF00118 Cpn60 TCP1 Pfam 4.795E-3 8.924E-3 4.274E-2
3.213E-1
1 15
34 3.50.7.10 - Gene3D 4.795E-3 8.924E-3 4.274E-2
3.213E-1
1 15
35 IPR027409 GroEL-like apical dom InterPro 4.795E-3 8.924E-3 4.274E-2
3.213E-1
1 15
36 IPR002423 Cpn60/TCP-1 InterPro 4.795E-3 8.924E-3 4.274E-2
3.213E-1
1 15
37 SM00568 GRAM SMART 5.114E-3 9.260E-3 4.435E-2
3.426E-1
1 16
38 PF00610 DEP Pfam 7.026E-3 1.121E-2
5.368E-2
4.707E-1
1 22
39 PS50186 DEP PROSITE 7.026E-3 1.121E-2
5.368E-2
4.707E-1
1 22
40 SM00049 DEP SMART 7.026E-3 1.121E-2
5.368E-2
4.707E-1
1 22
41 PF02893 GRAM Pfam 7.026E-3 1.121E-2
5.368E-2
4.707E-1
1 22
42 IPR004182 GRAM InterPro 7.026E-3 1.121E-2
5.368E-2
4.707E-1
1 22
43 IPR000591 DEP dom InterPro 7.344E-3 1.144E-2
5.481E-2
4.921E-1
1 23
44 SM00064 FYVE SMART 9.253E-3 1.378E-2
6.598E-2
6.199E-1
1 29
45 PF01363 FYVE Pfam 9.253E-3 1.378E-2
6.598E-2
6.199E-1
1 29
46 IPR017455 Znf FYVE-rel InterPro 1.084E-2 1.579E-2
7.562E-2
7.263E-1
1 34
47 IPR000306 Znf FYVE InterPro 1.211E-2 1.726E-2
8.268E-2
8.114E-1
1 38
48 PS50178 ZF FYVE PROSITE 1.274E-2 1.779E-2
8.519E-2
8.538E-1
1 40
49 PF02985 HEAT Pfam 1.528E-2 2.089E-2
1.000E-1
1.000E0
1 48
50 IPR000357 HEAT InterPro 1.843E-2 2.416E-2
1.157E-1
1.000E0
1 58
Show 45 more annotations

7: Pathway [Display Chart] 6 input genes in category / 31 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1270082 Synthesis of PIPs at the late endosome membrane BioSystems: REACTOME 3.146E-12 9.752E-11 3.927E-10 9.752E-11 4 10
2 1270079 Synthesis of PIPs at the early endosome membrane BioSystems: REACTOME 1.499E-11 2.323E-10 9.355E-10 4.646E-10 4 14
3 1270073 PI Metabolism BioSystems: REACTOME 2.231E-8 2.305E-7 9.283E-7 6.915E-7 4 79
4 1270075 Synthesis of PIPs at the Golgi membrane BioSystems: REACTOME 6.010E-8 4.657E-7 1.876E-6 1.863E-6 3 19
5 1270053 Phospholipid metabolism BioSystems: REACTOME 1.106E-6 6.858E-6 2.762E-5 3.429E-5 4 208
6 545314 3-phosphoinositide biosynthesis BioSystems: BIOCYC 6.758E-5 3.491E-4 1.406E-3 2.095E-3 2 27
7 547492 superpathway of inositol phosphate compounds BioSystems: BIOCYC 4.095E-4 1.814E-3 7.304E-3 1.270E-2 2 66
8 82987 Inositol phosphate metabolism BioSystems: KEGG 4.739E-4 1.836E-3 7.396E-3 1.469E-2 2 71
9 83052 Phosphatidylinositol signaling system BioSystems: KEGG 8.830E-4 3.042E-3 1.225E-2 2.737E-2 2 97
10 P00005 Angiogenesis PantherDB 2.095E-3 6.496E-3 2.616E-2
6.496E-2
2 150
11 1383031 PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 BioSystems: REACTOME 4.330E-3 1.220E-2 4.915E-2
1.342E-1
1 9
12 1427866 RET signaling BioSystems: REACTOME 6.779E-3 1.719E-2
6.923E-2
2.102E-1
2 273
13 SMP00011 Inositol Metabolism SMPDB 7.209E-3 1.719E-2
6.923E-2
2.235E-1
1 15
14 1269374 Tie2 Signaling BioSystems: REACTOME 8.645E-3 1.914E-2
7.709E-2
2.680E-1
1 18
15 137915 Signaling events regulated by Ret tyrosine kinase BioSystems: Pathway Interaction Database 1.818E-2 3.757E-2
1.513E-1
5.635E-1
1 38
16 138026 Insulin Pathway BioSystems: Pathway Interaction Database 2.055E-2 3.801E-2
1.531E-1
6.370E-1
1 43
17 137917 Angiopoietin receptor Tie2-mediated signaling BioSystems: Pathway Interaction Database 2.292E-2 3.801E-2
1.531E-1
7.104E-1
1 48
18 138017 Signaling events mediated by PTP1B BioSystems: Pathway Interaction Database 2.386E-2 3.801E-2
1.531E-1
7.397E-1
1 50
19 138068 Signaling events mediated by Stem cell factor receptor (c-Kit) BioSystems: Pathway Interaction Database 2.480E-2 3.801E-2
1.531E-1
7.690E-1
1 52
20 137976 IL2-mediated signaling events BioSystems: Pathway Interaction Database 2.480E-2 3.801E-2
1.531E-1
7.690E-1
1 52
21 138071 PDGFR-beta signaling pathway BioSystems: Pathway Interaction Database 2.575E-2 3.801E-2
1.531E-1
7.982E-1
1 54
22 138050 Fc-epsilon receptor I signaling in mast cells BioSystems: Pathway Interaction Database 2.810E-2 3.960E-2
1.595E-1
8.712E-1
1 59
23 137933 IL4-mediated signaling events BioSystems: Pathway Interaction Database 2.999E-2 4.009E-2
1.615E-1
9.296E-1
1 63
24 138058 BCR signaling pathway BioSystems: Pathway Interaction Database 3.139E-2 4.009E-2
1.615E-1
9.732E-1
1 66
25 1383025 Signaling by PTK6 BioSystems: REACTOME 3.233E-2 4.009E-2
1.615E-1
1.000E0
1 68
Show 20 more annotations

8: Pubmed [Display Chart] 6 input genes in category / 354 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 19840946 PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
2 19037259 VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
3 17556371 Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
4 18950639 ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
5 23047693 In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
6 22028665 Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. Pubmed 2.154E-12 1.271E-10 8.195E-10 7.625E-10 3 3
7 22696681 Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Pubmed 4.307E-11 2.178E-9 1.405E-8 1.525E-8 3 6
8 15542851 A mammalian ortholog of Saccharomyces cerevisiae Vac14 that associates with and up-regulates PIKfyve phosphoinositide 5-kinase activity. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
9 19793721 Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
10 17827176 Dok-1 is a positive regulator of IL-4 signalling and IgE response. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
11 26405034 The Protein Complex of Neurodegeneration-related Phosphoinositide Phosphatase Sac3 and ArPIKfyve Binds the Lewy Body-associated Synphilin-1, Preventing Its Aggregation. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
12 27664281 Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
13 21732353 Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
14 17329234 Dok-1 and Dok-2 are negative regulators of T cell receptor signaling. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
15 25252871 Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML). Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
16 15699069 Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
17 16177091 Phosphotyrosine binding-mediated oligomerization of downstream of tyrosine kinase (Dok)-1 and Dok-2 is involved in CD2-induced Dok phosphorylation. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
18 22842785 Modulation of synaptic function by VAC14, a protein that regulates the phosphoinositides PI(3,5)Pâ?? and PI(5)P. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
19 19299694 Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
20 21655088 Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
21 15611294 Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
22 14647425 Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
23 24963146 Dok1 and Dok2 proteins regulate natural killer cell development and function. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
24 15611295 Role of Dok-1 and Dok-2 in leukemia suppression. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
25 28490594 Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8(+) T Cells in a Murine Model of Ocular Infection. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
26 27183638 Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
27 20630877 ArPIKfyve regulates Sac3 protein abundance and turnover: disruption of the mechanism by Sac3I41T mutation causing Charcot-Marie-Tooth 4J disorder. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
28 17475247 ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
29 23659921 Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
30 16823827 All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells. Pubmed 2.057E-8 2.427E-7 1.565E-6 7.281E-6 2 2
31 27265473 Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
32 26125944 The Amyloid Precursor Protein Controls PIKfyve Function. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
33 22370159 The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
34 22736313 Dok-1 overexpression promotes development of γδ natural killer T cells. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
35 26934981 A cell-permeable tool for analysing APP intracellular domain function and manipulation of PIKfyve activity. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
36 20548287 Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
37 26216398 APP controls the formation of PI(3,5)P(2) vesicles through its binding of the PIKfyve complex. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
38 21078907 Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
39 23205702 Dok adaptors play anti-inflammatory roles in pulmonary homeostasis. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
40 20139980 Identification of DOK genes as lung tumor suppressors. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
41 29548825 Dok-3 and Dok-1/-2 adaptors play distinctive roles in cell fusion and proliferation during osteoclastogenesis and cooperatively protect mice from osteopenia. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
42 24600036 PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3. Pubmed 6.170E-8 5.200E-7 3.353E-6 2.184E-5 2 3
43 27450811 Loss of Dok-1 and Dok-2 in mice causes severe experimental colitis accompanied by reduced expression of IL-17A and IL-22. Pubmed 1.234E-7 9.495E-7 6.122E-6 4.368E-5 2 4
44 17092301 Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3. Pubmed 1.234E-7 9.495E-7 6.122E-6 4.368E-5 2 4
45 18429927 Endosomal phosphoinositides and human diseases. Pubmed 1.234E-7 9.495E-7 6.122E-6 4.368E-5 2 4
46 9478921 Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. Pubmed 1.234E-7 9.495E-7 6.122E-6 4.368E-5 2 4
47 10822173 The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells. Pubmed 2.056E-7 1.516E-6 9.778E-6 7.279E-5 2 5
48 10799545 Evidence that Llck-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling. Pubmed 2.056E-7 1.516E-6 9.778E-6 7.279E-5 2 5
49 26885983 The C-terminal cytoplasmic tail of hedgehog receptor Patched1 is a platform for E3 ubiquitin ligase complexes. Pubmed 2.194E-7 1.585E-6 1.022E-5 7.766E-5 3 86
50 18774718 PtdIns5P regulation through evolution: roles in membrane trafficking? Pubmed 3.084E-7 2.184E-6 1.408E-5 1.092E-4 2 6
Show 45 more annotations

9: Interaction [Display Chart] 6 input genes in category / 209 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:FIG4 FIG4 interactions 1.816E-9 3.795E-7 2.247E-6 3.795E-7 3 9
2 int:PIKFYVE PIKFYVE interactions 1.762E-8 1.841E-6 1.090E-5 3.682E-6 3 18
3 int:ANK1 ANK1 interactions 9.689E-8 6.750E-6 3.997E-5 2.025E-5 3 31
4 int:VAC14 VAC14 interactions 2.959E-6 1.546E-4 9.157E-4 6.185E-4 3 95
5 int:PTCH1 PTCH1 interactions 2.266E-5 9.473E-4 5.610E-3 4.736E-3 3 187
6 int:MTMR9 MTMR9 interactions 3.871E-5 1.348E-3 7.985E-3 8.090E-3 2 29
7 int:DOK3 DOK3 interactions 6.342E-5 1.894E-3 1.121E-2 1.326E-2 2 37
8 int:CRK CRK interactions 8.389E-5 1.995E-3 1.181E-2 1.753E-2 3 290
9 int:DOK2 DOK2 interactions 8.591E-5 1.995E-3 1.181E-2 1.796E-2 2 43
10 int:DOK1 DOK1 interactions 1.309E-4 2.736E-3 1.620E-2 2.736E-2 2 53
11 int:RET RET interactions 1.794E-4 3.409E-3 2.019E-2 3.749E-2 2 62
12 int:INPP5D INPP5D interactions 2.354E-4 4.100E-3 2.428E-2 4.920E-2 2 71
13 int:RASA1 RASA1 interactions 3.375E-4 5.426E-3 3.213E-2
7.054E-2
2 85
14 int:HCK HCK interactions 3.953E-4 5.902E-3 3.495E-2
8.262E-2
2 92
15 int:BCR BCR interactions 4.669E-4 6.506E-3 3.853E-2
9.759E-2
2 100
16 int:JMJD7 JMJD7 interactions 6.778E-4 7.509E-3 4.447E-2
1.417E-1
1 2
17 int:LPAL2 LPAL2 interactions 6.778E-4 7.509E-3 4.447E-2
1.417E-1
1 2
18 int:LINC00518 LINC00518 interactions 6.778E-4 7.509E-3 4.447E-2
1.417E-1
1 2
19 int:NCK1 NCK1 interactions 6.826E-4 7.509E-3 4.447E-2
1.427E-1
2 121
20 int:NCK2 NCK2 interactions 9.123E-4 9.039E-3
5.353E-2
1.907E-1
2 140
21 int:CRKL CRKL interactions 9.253E-4 9.039E-3
5.353E-2
1.934E-1
2 141
22 int:LCK LCK interactions 9.515E-4 9.039E-3
5.353E-2
1.989E-1
2 143
23 int:CDRT4 CDRT4 interactions 1.016E-3 9.237E-3
5.470E-2
2.124E-1
1 3
24 int:PLCG1 PLCG1 interactions 1.310E-3 1.133E-2
6.709E-2
2.737E-1
2 168
25 int:C4orf33 C4orf33 interactions 1.355E-3 1.133E-2
6.709E-2
2.832E-1
1 4
26 int:ZNF34 ZNF34 interactions 1.694E-3 1.361E-2
8.062E-2
3.540E-1
1 5
27 int:ZCWPW1 ZCWPW1 interactions 2.032E-3 1.517E-2
8.983E-2
4.247E-1
1 6
28 int:KRTAP19-7 KRTAP19-7 interactions 2.032E-3 1.517E-2
8.983E-2
4.247E-1
1 6
29 int:ABL1 ABL1 interactions 2.353E-3 1.548E-2
9.168E-2
4.918E-1
2 226
30 int:LCAT LCAT interactions 2.370E-3 1.548E-2
9.168E-2
4.954E-1
1 7
31 int:ACSS1 ACSS1 interactions 2.370E-3 1.548E-2
9.168E-2
4.954E-1
1 7
32 int:PHYKPL PHYKPL interactions 2.370E-3 1.548E-2
9.168E-2
4.954E-1
1 7
33 int:LYN LYN interactions 2.478E-3 1.553E-2
9.198E-2
5.178E-1
2 232
34 int:PRADC1 PRADC1 interactions 2.709E-3 1.553E-2
9.198E-2
5.661E-1
1 8
35 int:HVCN1 HVCN1 interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
36 int:SPRYD7 SPRYD7 interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
37 int:GALT GALT interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
38 int:TMEM38A TMEM38A interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
39 int:NUDT16 NUDT16 interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
40 int:SEPSECS SEPSECS interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
41 int:SMUG1 SMUG1 interactions 3.047E-3 1.553E-2
9.198E-2
6.368E-1
1 9
42 int:CNTN2 CNTN2 interactions 3.385E-3 1.645E-2
9.743E-2
7.075E-1
1 10
43 int:EVI2A EVI2A interactions 3.385E-3 1.645E-2
9.743E-2
7.075E-1
1 10
44 int:SHC1 SHC1 interactions 3.535E-3 1.679E-2
9.945E-2
7.389E-1
2 278
45 int:MPPED2 MPPED2 interactions 3.723E-3 1.697E-2
1.005E-1
7.781E-1
1 11
46 int:KYAT1 KYAT1 interactions 4.061E-3 1.697E-2
1.005E-1
8.487E-1
1 12
47 int:KRTAP19-5 KRTAP19-5 interactions 4.061E-3 1.697E-2
1.005E-1
8.487E-1
1 12
48 int:SIGLEC5 SIGLEC5 interactions 4.061E-3 1.697E-2
1.005E-1
8.487E-1
1 12
49 int:PPIP5K1 PPIP5K1 interactions 4.061E-3 1.697E-2
1.005E-1
8.487E-1
1 12
50 int:FAM120B FAM120B interactions 4.061E-3 1.697E-2
1.005E-1
8.487E-1
1 12
Show 45 more annotations

10: Cytoband [Display Chart] 6 input genes in category / 6 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 11q22 11q22 1.903E-3 1.002E-2 2.455E-2 1.142E-2 1 11
2 2p13 2p13 4.148E-3 1.002E-2 2.455E-2 2.489E-2 1 24
3 2q34 2q34 5.010E-3 1.002E-2 2.455E-2 3.006E-2 1 29
4 8p21.3 8p21.3 6.733E-3 1.010E-2 2.474E-2 4.040E-2 1 39
5 6q21 6q21 1.770E-2 1.957E-2 4.796E-2
1.062E-1
1 103
6 16q22.1 16q22.1 1.957E-2 1.957E-2 4.796E-2
1.174E-1
1 114
Show 1 more annotation

11: Transcription Factor Binding Site [Display Chart] 5 input genes in category / 26 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 3 input genes in category / 3 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1079 Atypical dual specificity phosphatases|Phosphoinositide phosphatases genenames.org 8.981E-6 2.694E-5 4.940E-5 2.694E-5 2 32
2 903 Myotubularins|Phosphoinositide phosphatases genenames.org 2.471E-3 3.707E-3 6.796E-3 7.414E-3 1 15
3 81 Zinc fingers FYVE-type genenames.org 5.103E-3 5.103E-3 9.356E-3 1.531E-2 1 31

13: Coexpression [Display Chart] 6 input genes in category / 603 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M6836 Genes up-regulated in CD4 [GeneID=920] T cells from lymph nodes: naïve versus day 7 after immunization. MSigDB C7: Immunologic Signatures (v6.0) 1.248E-5 7.528E-3
5.255E-2
7.528E-3 3 200
2 M8288 Genes down-regulated in lupus susceptibility locus Sle2c1 B lymphocytes from: peritoneal cavity versus spleen. MSigDB C7: Immunologic Signatures (v6.0) 1.047E-3 4.149E-2
2.896E-1
6.315E-1
2 196
3 M5361 Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h. MSigDB C7: Immunologic Signatures (v6.0) 1.058E-3 4.149E-2
2.896E-1
6.379E-1
2 197
4 M6505 Genes up-regulated in monocyte-derived dendritic cells: LGALS1 [GeneID=3956] versus vehicle. MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 4.149E-2
2.896E-1
6.508E-1
2 199
5 M5358 Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 24 h. MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 4.149E-2
2.896E-1
6.508E-1
2 199
6 M7655 Genes up-regulated in skin gamma delta T cells: healthy versus obesity. MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 4.149E-2
2.896E-1
6.508E-1
2 199
7 M8421 Genes up-regulated in brain microglia versus spleen CD8- dendritic cells. MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 4.149E-2
2.896E-1
6.508E-1
2 199
8 M6613 Genes up-regulated in bone marrow-derived macrophages (45 min): IL10 [GeneID=3486] and LPS versus IL6 [GeneID=3469] and LPS. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
9 M5147 Genes up-regulated in untreated dendritic cells (DC) versus DCs exposed to parasite Toxoplasma gondii. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
10 M7650 Genes up-regulated in CD4 [GeneID=920] T cells under specific pathogen free conditions: healthy versus arthritis (KRN model). MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
11 M4300 Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 IL2RA [GeneID=3559] high T cells at. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
12 M5848 Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist). MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
13 M3927 Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
14 M5187 Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
15 M7665 Genes up-regulated in the in vitro follicular dendritic cells from peripheral lymph nodes: non-stimulated versus tretinoin [PubChem=444795] and Pam2CSK4 (96h). MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 4.149E-2
2.896E-1
6.573E-1
2 200
16 M10941 Genes up-regulated in BJUB cells (B-lymphoma) in response to rapamycin (sirolimus) [PubChem=6610346] treatment. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.101E-3 4.149E-2
2.896E-1
6.638E-1
2 201
Show 11 more annotations

14: Coexpression Atlas [Display Chart] 6 input genes in category / 254 annotations before applied cutoff / 21829 genes in category

No results to display

15: Computational [Display Chart] 5 input genes in category / 70 annotations before applied cutoff / 10037 genes in category

No results to display

16: MicroRNA [Display Chart] 6 input genes in category / 148 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-377-3p:Non-Functional MTI Non-Functional MTI miRTarbase 2.006E-4 1.914E-2
1.068E-1
2.969E-2 2 266
2 hsa-miR-342-5p:mirSVR highEffct hsa-miR-342-5p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 3.407E-4 1.914E-2
1.068E-1
5.043E-2
2 347
3 hsa-miR-1225-5p:mirSVR highEffct hsa-miR-1225-5p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 4.320E-4 1.914E-2
1.068E-1
6.394E-2
2 391
4 hsa-miR-3941:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.195E-4 1.914E-2
1.068E-1
7.688E-2
2 429
5 hsa-miR-101:PITA hsa-miR-101:PITA TOP PITA 6.466E-4 1.914E-2
1.068E-1
9.570E-2
2 479
6 hsa-miR-325:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.655E-3 4.026E-2
2.245E-1
3.929E-1
1 32
7 hsa-miR-1284:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.063E-3 4.026E-2
2.245E-1
6.013E-1
1 49
8 hsa-miR-5689:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.808E-3 4.026E-2
2.245E-1
7.115E-1
1 58
9 hsa-miR-508-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.890E-3 4.026E-2
2.245E-1
7.238E-1
1 59
10 TACAATC,MIR-508:MSigDB TACAATC,MIR-508:MSigDB MSigDB 5.056E-3 4.026E-2
2.245E-1
7.483E-1
1 61
11 hsa-miR-4321:mirSVR highEffct hsa-miR-4321:mirSVR nonconserved highEffect-0.5 MicroRNA.org 5.552E-3 4.026E-2
2.245E-1
8.217E-1
1 67
12 hsa-miR-6882-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.717E-3 4.026E-2
2.245E-1
8.462E-1
1 69
13 hsa-miR-124-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.883E-3 4.026E-2
2.245E-1
8.706E-1
1 71
14 hsa-miR-589-5p:Functional MTI Functional MTI miRTarbase 5.883E-3 4.026E-2
2.245E-1
8.706E-1
1 71
15 hsa-miR-6884-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.048E-3 4.026E-2
2.245E-1
8.951E-1
1 73
16 hsa-miR-379:PITA hsa-miR-379:PITA TOP PITA 6.378E-3 4.026E-2
2.245E-1
9.440E-1
1 77
17 hsa-miR-6889-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.874E-3 4.026E-2
2.245E-1
1.000E0
1 83
18 hsa-miR-365b-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.204E-3 4.026E-2
2.245E-1
1.000E0
1 87
19 hsa-miR-379-5p:TargetScan hsa-miR-379-5p TargetScan 7.617E-3 4.026E-2
2.245E-1
1.000E0
1 92
20 hsa-miR-4418:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.360E-3 4.026E-2
2.245E-1
1.000E0
1 101
21 hsa-miR-509-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.525E-3 4.026E-2
2.245E-1
1.000E0
1 103
22 hsa-miR-509-3-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.607E-3 4.026E-2
2.245E-1
1.000E0
1 104
23 hsa-miR-1184:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.184E-3 4.026E-2
2.245E-1
1.000E0
1 111
24 hsa-miR-376a-3p:Non-Functional MTI Non-Functional MTI miRTarbase 9.267E-3 4.026E-2
2.245E-1
1.000E0
1 112
25 hsa-miR-4715-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.349E-3 4.026E-2
2.245E-1
1.000E0
1 113
26 hsa-miR-300:Functional MTI Functional MTI miRTarbase 9.761E-3 4.026E-2
2.245E-1
1.000E0
1 118
27 hsa-miR-365a-3p:Functional MTI Functional MTI miRTarbase 1.026E-2 4.026E-2
2.245E-1
1.000E0
1 124
28 hsa-miR-3180-3p:mirSVR highEffct hsa-miR-3180-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.042E-2 4.026E-2
2.245E-1
1.000E0
1 126
29 hsa-miR-328-3p:Functional MTI Functional MTI miRTarbase 1.091E-2 4.026E-2
2.245E-1
1.000E0
1 132
30 hsa-miR-381-3p:Functional MTI Functional MTI miRTarbase 1.124E-2 4.026E-2
2.245E-1
1.000E0
1 136
31 hsa-miR-7156-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.133E-2 4.026E-2
2.245E-1
1.000E0
1 137
32 hsa-miR-362-5p:TargetScan hsa-miR-362-5p TargetScan 1.174E-2 4.026E-2
2.245E-1
1.000E0
1 142
33 hsa-miR-508-3p:PITA hsa-miR-508-3p:PITA TOP PITA 1.182E-2 4.026E-2
2.245E-1
1.000E0
1 143
34 hsa-miR-141-3p:Functional MTI Functional MTI miRTarbase 1.198E-2 4.026E-2
2.245E-1
1.000E0
1 145
35 hsa-miR-6768-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.223E-2 4.026E-2
2.245E-1
1.000E0
1 148
36 hsa-miR-200a-3p:Functional MTI Functional MTI miRTarbase 1.239E-2 4.026E-2
2.245E-1
1.000E0
1 150
37 hsa-miR-429:Functional MTI Functional MTI miRTarbase 1.248E-2 4.026E-2
2.245E-1
1.000E0
1 151
38 hsa-miR-4267:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.297E-2 4.026E-2
2.245E-1
1.000E0
1 157
39 hsa-miR-545-3p:Non-Functional MTI Non-Functional MTI miRTarbase 1.363E-2 4.026E-2
2.245E-1
1.000E0
1 165
40 hsa-miR-4778-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.445E-2 4.026E-2
2.245E-1
1.000E0
1 175
41 hsa-miR-106a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.502E-2 4.026E-2
2.245E-1
1.000E0
1 182
42 hsa-miR-765:PITA hsa-miR-765:PITA TOP PITA 1.510E-2 4.026E-2
2.245E-1
1.000E0
1 183
43 hsa-miR-200b-3p:Functional MTI Functional MTI miRTarbase 1.535E-2 4.026E-2
2.245E-1
1.000E0
1 186
44 GTATTAT,MIR-369-3P:MSigDB GTATTAT,MIR-369-3P:MSigDB MSigDB 1.568E-2 4.026E-2
2.245E-1
1.000E0
1 190
45 GGGACCA,MIR-133B:MSigDB GGGACCA,MIR-133B:MSigDB MSigDB 1.568E-2 4.026E-2
2.245E-1
1.000E0
1 190
46 GGGACCA,MIR-133A:MSigDB GGGACCA,MIR-133A:MSigDB MSigDB 1.568E-2 4.026E-2
2.245E-1
1.000E0
1 190
47 hsa-miR-4476:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.642E-2 4.026E-2
2.245E-1
1.000E0
1 199
48 hsa-miR-6876-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.642E-2 4.026E-2
2.245E-1
1.000E0
1 199
49 hsa-miR-100:mirSVR lowEffct hsa-miR-100:mirSVR conserved lowEffect-0.1-0.5 MicroRNA.org 1.658E-2 4.026E-2
2.245E-1
1.000E0
1 201
50 hsa-miR-376b-3p:TargetScan hsa-miR-376b-3p TargetScan 1.666E-2 4.026E-2
2.245E-1
1.000E0
1 202
Show 45 more annotations

17: Drug [Display Chart] 6 input genes in category / 1575 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID000643964 PtdIns(3)P Stitch 4.935E-8 3.840E-5 3.049E-4 7.773E-5 4 175
2 CID006857352 AC1OAGFW Stitch 6.171E-8 3.840E-5 3.049E-4 9.719E-5 4 185
3 CID006857413 AC1OAGKW Stitch 7.315E-8 3.840E-5 3.049E-4 1.152E-4 4 193
4 CID000643965 PtdIns(4)P Stitch 1.816E-6 7.150E-4 5.677E-3 2.860E-3 3 104
5 CID000445522 H-Mn Stitch 1.418E-4 2.552E-2
2.026E-1
2.233E-1
2 71
6 CID000173651 ML-236A Stitch 5.046E-4 2.552E-2
2.026E-1
7.947E-1
2 134
7 CID000446005 1h6h Stitch 7.879E-4 2.552E-2
2.026E-1
1.000E0
1 3
8 CID000453624 AC1L9R2Z Stitch 7.912E-4 2.552E-2
2.026E-1
1.000E0
2 168
9 CID000023932 molybdenum Stitch 9.174E-4 2.552E-2
2.026E-1
1.000E0
2 181
10 1561 UP Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A Broad Institute CMAP Up 1.021E-3 2.552E-2
2.026E-1
1.000E0
2 191
11 489 UP radicicol; Up 200; 0.1uM; MCF7; HG-U133A Broad Institute CMAP Up 1.021E-3 2.552E-2
2.026E-1
1.000E0
2 191
12 7376 DN Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.021E-3 2.552E-2
2.026E-1
1.000E0
2 191
13 6207 DN Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.031E-3 2.552E-2
2.026E-1
1.000E0
2 192
14 6914 UP carmustine; Up 200; 100uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.031E-3 2.552E-2
2.026E-1
1.000E0
2 192
15 CID009549284 MEK1/2 inhibitor Stitch 1.042E-3 2.552E-2
2.026E-1
1.000E0
2 193
16 6223 DN Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.042E-3 2.552E-2
2.026E-1
1.000E0
2 193
17 7000 UP estradiol, USP; Up 200; 0.01uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.053E-3 2.552E-2
2.026E-1
1.000E0
2 194
18 1330 DN Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT HG-U133A Broad Institute CMAP Down 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
19 1911 UP Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A Broad Institute CMAP Up 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
20 1401 DN Tranexamic acid [1197-18-8]; Down 200; 25.4uM; HL60; HG-U133A Broad Institute CMAP Down 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
21 7444 DN Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
22 6825 DN Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
23 421 UP trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A Broad Institute CMAP Up 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
24 1532 DN Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.063E-3 2.552E-2
2.026E-1
1.000E0
2 195
25 1367 DN Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A Broad Institute CMAP Down 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
26 1968 UP Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A Broad Institute CMAP Up 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
27 3729 UP Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
28 639 UP pentamidine isethionate salt; Up 200; 100uM; MCF7; HG-U133A Broad Institute CMAP Up 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
29 2033 UP Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A Broad Institute CMAP Up 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
30 6229 UP Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.074E-3 2.552E-2
2.026E-1
1.000E0
2 196
31 6815 DN Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
32 1641 DN LY 294002; Down 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
33 5488 UP Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
34 5482 UP Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
35 6050 DN Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
36 7264 UP Clorsulon [60200-06-8]; Up 200; 10.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
37 4993 UP Estrone [53-16-7]; Up 200; 14.8uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
38 3550 DN Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
39 1972 UP Levodopa [59-92-7]; Up 200; 20.2uM; HL60; HG-U133A Broad Institute CMAP Up 1.085E-3 2.552E-2
2.026E-1
1.000E0
2 197
40 5789 UP Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
41 3722 UP Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
42 5778 UP Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
43 7013 DN Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
44 5015 UP Benzbromarone [3562-84-3]; Up 200; 9.4uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
45 3621 DN Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
46 1981 UP Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; HL60; HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
47 1299 DN Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT HG-U133A Broad Institute CMAP Down 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
48 1377 UP Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
49 1969 DN Dibucaine [85-79-0]; Down 200; 11.6uM; HL60; HG-U133A Broad Institute CMAP Down 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
50 1963 UP Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A Broad Institute CMAP Up 1.096E-3 2.552E-2
2.026E-1
1.000E0
2 198
Show 45 more annotations

18: Disease [Display Chart] 6 input genes in category / 210 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C1970011 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J DisGeNET Curated 3.427E-7 7.196E-5 4.265E-4 7.196E-5 2 3
2 C0007959 Charcot-Marie-Tooth Disease DisGeNET Curated 1.463E-5 1.536E-3 9.106E-3 3.073E-3 3 148
3 C0027888 Hereditary Motor and Sensory Neuropathies DisGeNET Curated 3.142E-5 2.199E-3 1.303E-2 6.598E-3 2 24
4 C0598589 Inherited neuropathies DisGeNET BeFree 9.772E-5 3.240E-3 1.920E-2 2.052E-2 2 42
5 C0270922 Peripheral demyelinating neuropathy DisGeNET Curated 1.123E-4 3.240E-3 1.920E-2 2.358E-2 2 45
6 C1847584 Distal sensory impairment DisGeNET Curated 1.503E-4 3.240E-3 1.920E-2 3.155E-2 2 52
7 C0427065 Distal muscle weakness DisGeNET Curated 2.139E-4 3.240E-3 1.920E-2 4.492E-2 2 62
8 C1864696 Distal limb muscle weakness due to peripheral neuropathy DisGeNET Curated 2.139E-4 3.240E-3 1.920E-2 4.492E-2 2 62
9 C4013648 POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL DisGeNET Curated 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
10 cv:C2675491 Amyotrophic lateral sclerosis type 11 Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
11 C2675491 AMYOTROPHIC LATERAL SCLEROSIS 11 DisGeNET Curated 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
12 cv:C2675191 Polymicrogyria, bilateral occipital Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
13 C4024922 Irregular myelin loops DisGeNET Curated 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
14 cv:C1832399 Charcot-Marie-Tooth disease, type 4B1 Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
15 OMIN:601382 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1 OMIM 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
16 cv:C1857663 Yunis Varon syndrome Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
17 cv:C1970011 Charcot-Marie-Tooth disease, type 4J Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
18 OMIN:121850 CORNEAL DYSTROPHY, FLECK OMIM 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
19 C0333457 Segmental demyelination DisGeNET BeFree 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
20 OMIN:612577 AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11 OMIM 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
21 C1857663 Yunis Varon syndrome DisGeNET Curated 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
22 OMIN:611228 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J OMIM 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
23 C1836213 Aplastic/hypoplastic halluces DisGeNET Curated 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
24 cv:C1562113 Fleck corneal dystrophy Clinical Variations 3.703E-4 3.240E-3 1.920E-2
7.775E-2
1 1
25 C1839042 Upper motor neuron dysfunction DisGeNET Curated 7.404E-4 5.759E-3 3.413E-2
1.555E-1
1 2
26 C4021167 Tapered toe DisGeNET Curated 7.404E-4 5.759E-3 3.413E-2
1.555E-1
1 2
27 C1859077 Absent/hypoplastic nails DisGeNET Curated 7.404E-4 5.759E-3 3.413E-2
1.555E-1
1 2
28 C1861336 Hypoplastic/aplastic distal phalanges DisGeNET Curated 1.110E-3 7.772E-3 4.606E-2
2.332E-1
1 3
29 C4025828 Abnormality of the scapula DisGeNET Curated 1.110E-3 7.772E-3 4.606E-2
2.332E-1
1 3
30 C1839276 Broad secondary alveolar ridge DisGeNET Curated 1.110E-3 7.772E-3 4.606E-2
2.332E-1
1 3
31 C1855514 Severe failure to thrive DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
32 C1857074 Absent sternal ossification DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
33 C4280557 Hypotrophic facial bones DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
34 C4280443 Absent bone maturation in sternum DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
35 C4280558 Flattening of facial bones DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
36 C1832399 Charcot-Marie-Tooth disease, Type 4B1 DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
37 C1846438 Hypoplastic facial bones DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
38 C0425795 Absent nipple (finding) DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
39 C4229090 Small facial bones DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
40 C4280268 Underdevelopment of facial bones DisGeNET Curated 1.480E-3 7.772E-3 4.606E-2
3.109E-1
1 4
41 C1862152 Short to absent middle phalanges DisGeNET Curated 1.850E-3 9.036E-3
5.355E-2
3.885E-1
1 5
42 C1504405 Pyramidal tract syndrome DisGeNET Curated 1.850E-3 9.036E-3
5.355E-2
3.885E-1
1 5
43 C4082197 Charcot-Marie-Tooth disease type 4 DisGeNET BeFree 1.850E-3 9.036E-3
5.355E-2
3.885E-1
1 5
44 C1857665 Aplastic clavicles DisGeNET Curated 2.220E-3 1.036E-2
6.140E-2
4.662E-1
1 6
45 C0078982 Arhinencephaly DisGeNET Curated 2.220E-3 1.036E-2
6.140E-2
4.662E-1
1 6
46 C1848977 Short upper lip DisGeNET Curated 2.589E-3 1.088E-2
6.446E-2
5.438E-1
1 7
47 C1832338 Axonal loss DisGeNET Curated 2.589E-3 1.088E-2
6.446E-2
5.438E-1
1 7
48 C0522216 Abnormal auditory evoked potential DisGeNET Curated 2.589E-3 1.088E-2
6.446E-2
5.438E-1
1 7
49 C0752282 Congenital Structural Myopathy DisGeNET Curated 2.589E-3 1.088E-2
6.446E-2
5.438E-1
1 7
50 C4024927 Peripheral hypomyelination DisGeNET Curated 2.589E-3 1.088E-2
6.446E-2
5.438E-1
1 7
Show 45 more annotations